Brazil Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Curious about BaaS? Get the full feature comparison in our free eBook comparing the time to create your own cloud backend to a Backend as a Service like Kinvey. From our sponsors

Brazil Pharmaceuticals and Healthcare Report Q4 2013 Sep 18th 2013, 00:00, by swapnil BMI View: Although Sanofi’s ‘disappointing quarter’ as well as currency devaluation in Brazil created certain market unease, the sales performance of multinationals has remained positive. The increasing demand for advanced medicines in the country continues to drive innovative drugmakers’ revenue growth. However, key factors to multinationals’ success, such as intimate relationship with Brazilian authorities and deeper integration with local drugmakers, may become their undoing in long-term. Multinationals will face more fierce generic competition and increasing intervention from local authorities. Headline Expenditure Projections ? Pharmaceuticals: BRL52.4bn (US$26.8bn) in 2012 to BRL57.0bn (US$26.6bn) in 2013; +8.7% in local currency terms and -1.0% … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116075. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/brazil-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions